Canopy Growth Corp. /zigman2/quotes/200603886/composite CGC -1.40% /zigman2/quotes/202205609/delayed CA:WEED -0.82% shares fell 11% in premarket trades Friday after it said its fourth-quarter loss narrowed to C$574.6 million, or $1.46 a share, from C$700 million, or $1.85 a share in the year-ago quarter. Revenue for the three months ended March 31 fell to C$126.1 million from C$167.4 million in the year-ago period. Analysts expected Constellation Brands Inc.-backed /zigman2/quotes/207737284/composite STZ +1.02% backed Canopy Growth to report a loss of 30 cents a share on revenue of C$129.9 million, according to FactSet. Looking ahead, Canopy Growth expects to generate positive adjusted Ebitda in fiscal year 2024, excluding investments in BioSteel drinks and its U.S. THC businesses. "Achieving profitability is critical and we have undertaken additional initiatives to streamline and drive efficiencies for our global cannabis business," said CEO David Klein. "In FY2023, we are focused on executing our path to profitability in Canada, while we continue to invest in high potential opportunities -- particularly in BioSteel, and further developing our U.S. THC ecosystem, which we believe remains significantly under-appreciated by the market." Prior to Friday's trades, shares of Canopy Growth are down 35.5% in 2022 compared to a drop of 25% by the Nasdaq and a loss of 41.9% by the Cannabis ETF /zigman2/quotes/213173823/composite THCX +5.15% .